BIOTHERAPY DURING CHRONIC INFLAMMATORY BOWEL DISEASE: AN OVER-RISK OF TUBERCULOSIS REACTIVATION?
Journal: International Journal of Advanced Research (Vol.10, No. 02)Publication Date: 2022-02-17
Authors : Hakima Abid Sarra Bahja Ibrahimi Sidi Adil; Mohammed El Abkari;
Page : 1033-1041
Keywords : IBD Anti TNF α- Latent Tuberculosis;
Abstract
Anti-TNFα have revolutionized the management of chronic inflammatory rheumatic and intestinal diseases however, they are at high risk of reactivation of latent tuberculosis. These are most often extra-pulmonary tuberculosis and disseminated forms which occur during the first year and which can be avoided by screening and prophylactic treatment. The aim of this publication is to describe the epidemiological, clinical, biological, radiological and evolving data of patients having triggered tuberculosis under anti TNFα treatment followed at the Hassan II hospital center (CHU) in Fez during the period between January 2012 and January 2021. During this period, we collected 130 patients under anti TNF alpha of which 84.5% of patients are on Infliximab 15.5% on Adalimumab. Active tuberculosis occurred in 4.6% of patients whose mean age is 35.5 years and the sex ration is 5H / 1F. The duration of onset is on average after 5 sessions of anti TNF alpha. A phtysio assessment was carried out in all our patients before starting the anti TNF α, 2 of which were IDR positive completed by quantifying it which came back positive in a single patient.
Other Latest Articles
- ANALYSIS OF LEAN MANUFACTURING WASTE FACTORS IN THE BREWING INDUSTRY OF ENSENADA, BAJA CALIFORNIA, MEXICO
- ANALYSIS OF LEAN MANUFACTURING WASTE FACTORS IN THE BREWING INDUSTRY OF ENSENADA, BAJA CALIFORNIA, MEXICO
- APPLICATION OF LEAN MANUFACTURING TOOLS AND ICT TO INCREASE PRODUCTIVITY LEVELS AND REDUCE COSTS IN THE BREWING INDUSTRY IN ENSENADA, BAJA CALIFORNIA, MEXICO
- ETUDE AU LABORATOIRE DE LACTIVITE LARVICIDE DE BACILLUS THURINGIENSIS ISRAELENSIS ET DE BACILLUS SPHAERICUS DANS LA PERSPECTIVE DUN CONTROLE BIOLOGIQUE DES LARVES DE CULEX PIPENS ET DANOPHELES GAMBIAE S.LAU NIGER
- THE EVOLUTION OF CAR T-CELL THERAPY: ETHICS AND EFFICIENCY
Last modified: 2022-03-26 21:31:25